TrialApplied health economics and health policy2019

Long-term Cost-effectiveness of Insulin Degludec Versus Insulin Glargine U100 in the UK: Evidence from the Basal-bolus Subgroup of the DEVOTE Trial (DEVOTE 16).

Richard F Pollock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.